Stock Events

Stock Events

Lipigon Pharmaceuticals AB 

SEK0
1
-SEK0-3.33% Today

Statistics

Day High
0
Day Low
0
52W High
0.19
52W Low
0
Volume
13,625,054
Avg. Volume
-
Mkt Cap
1.76M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

24MayExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q1 2024
-1.07
-0.7
-0.33
0.04
Expected EPS
N/A
Actual EPS
N/A

Financials

-245.59%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
20.57MRevenue
-50.53MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LPGO.ST. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Lipigon Pharmaceuticals AB (publ), a clinical-stage pharmaceutical company, develops drugs for lipid related diseases in Sweden. Its product pipeline consists of Lipisense project, which is in phase II for the treatment of severe hypertriglyceridemia disease; Dyslipidemia project, which is in preclinical trial to treat cardiovascular disease and severe hypertriglyceridemia; and CAP project, which is in preclinical trial to treat and prevent lung injury associated with community-acquired pneumonia. The company has a license agreement with Leaderna for the development of Lipisense. The company was incorporated in 2010 and is based in Umeå, Sweden.
Show more...
CEO
Mr. Lars Ohman
Employees
7
Country
Sweden
ISIN
SE0015382072

Listings

MU
DE
9RP.MU
STU
DE
9RP.STU
F
DE
9RP.F
ST
SE
LPGO.ST

0 Comments

Share your thoughts

FAQ

What is Lipigon Pharmaceuticals AB stock price today?▼
The current price of LPGO.ST is SEK0 SEK — it has decreased by -3.33% in the past 24 hours. Watch Lipigon Pharmaceuticals AB stock price performance more closely on the chart.
What is Lipigon Pharmaceuticals AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lipigon Pharmaceuticals AB stocks are traded under the ticker LPGO.ST.
Is Lipigon Pharmaceuticals AB stock price growing?▼
LPGO.ST stock has fallen by -25.64% compared to the previous week, the month change is a -50% fall, over the last year Lipigon Pharmaceuticals AB has showed a -97.58% decrease.
What is Lipigon Pharmaceuticals AB market cap?▼
Today Lipigon Pharmaceuticals AB has the market capitalization of 1.76M
What is Lipigon Pharmaceuticals AB revenue for the last year?▼
Lipigon Pharmaceuticals AB revenue for the last year amounts to 20.57M SEK.
What is Lipigon Pharmaceuticals AB net income for the last year?▼
LPGO.ST net income for the last year is -50.53M SEK.
How many employees does Lipigon Pharmaceuticals AB have?▼
As of April 29, 2026, the company has 7 employees.
In which sector is Lipigon Pharmaceuticals AB located?▼
Lipigon Pharmaceuticals AB operates in the Health & Wellness sector.
When did Lipigon Pharmaceuticals AB complete a stock split?▼
Lipigon Pharmaceuticals AB has not had any recent stock splits.
Where is Lipigon Pharmaceuticals AB headquartered?▼
Lipigon Pharmaceuticals AB is headquartered in Umeå, Sweden.